We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$971M
AUM Growth
+$184M
Cap. Flow
+$141M
Cap. Flow %
14.52%
Top 10 Hldgs %
59.64%
Holding
36
New
9
Increased
10
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$79.3M
2
CTLT
CATALENT, INC.
CTLT
+$65.2M
3
WAT icon
Waters Corp
WAT
+$53.8M
4
ISRG icon
Intuitive Surgical
ISRG
+$46.3M
5
GH icon
Guardant Health
GH
+$33.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$59.5M
2
LH icon
Labcorp
LH
+$43.4M
3
HAE icon
Haemonetics
HAE
+$36.6M
4
SGRY icon
Surgery Partners
SGRY
+$32.1M
5
ZBH icon
Zimmer Biomet
ZBH
+$25.8M

Sector Composition

Rank Sector Weight
1 Healthcare 98.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
Humana
HUM
$45.8B
$80.4M 8.28%
+181,512
New +$79.3M
CTLT
2
DELISTED
CATALENT, INC.
CTLT
$65.8M 6.78%
+608,429
New +$65.2M
MOH icon
3
Molina Healthcare
MOH
$10.4B
$60M 6.18%
237,213
+37,213
+19% +$9.35M
ABBV icon
4
AbbVie
ABBV
$454B
$60M 6.18%
532,523
+232,523
+78% +$26.2M
WAT icon
5
Waters Corp
WAT
$36.4B
$58.8M 6.05%
+169,999
New +$53.8M
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$57.9M 5.97%
618,573
+118,573
+24% +$10.9M
CRL icon
7
Charles River Laboratories
CRL
$10.8B
$54.7M 5.64%
147,928
+7,928
+6% +$2.65M
ISRG icon
8
Intuitive Surgical
ISRG
$128B
$50.6M 5.21%
+164,997
New +$46.3M
NVRO
9
DELISTED
NEVRO CORP.
NVRO
$46.9M 4.83%
282,620
+102,620
+57% +$16M
EHC icon
10
Encompass Health
EHC
$11.3B
$44M 4.53%
708,454
-265,721
-27% -$17.7M
GH icon
11
Guardant Health
GH
$19.3B
$43.5M 4.48%
350,000
+250,000
+250% +$33.6M
ALGN icon
12
Align Technology
ALGN
$12B
$39.7M 4.09%
65,000
-5,000
-7% -$2.96M
NVST icon
13
Envista
NVST
$4.34B
$38.9M 4.01%
900,000
-10,000
-1% -$434K
ZBH icon
14
Zimmer Biomet
ZBH
$17.8B
$34.6M 3.56%
221,598
-159,502
-42% -$25.8M
PACB icon
15
Pacific Biosciences
PACB
$422M
$34.1M 3.52%
976,245
+40,440
+4% +$1.18M
THC icon
16
Tenet Healthcare
THC
$21B
$32.4M 3.34%
+484,005
New +$30M
IDXX icon
17
Idexx Laboratories
IDXX
$43.9B
$31.6M 3.25%
50,000
+15,000
+43% +$8.28M
OSH
18
DELISTED
Oak Street Health, Inc.
OSH
$31.4M 3.23%
535,528
+185,528
+53% +$11M
CNMD icon
19
CONMED
CNMD
$1.31B
$29.9M 3.07%
217,204
+17,204
+9% +$2.36M
LUNG icon
20
Pulmonx
LUNG
$51.5M
$24.3M 2.5%
550,000
-50,000
-8% -$2.18M
ICLR icon
21
Icon
ICLR
$13B
$17.6M 1.81%
+85,000
New +$18.3M
CANO
22
DELISTED
Cano Health, Inc.
CANO
$10.9M 1.12%
+9,000
New +$12.1M
DMTK
23
DELISTED
DermTech, Inc. Common Stock
DMTK
$10.4M 1.07%
250,000
– –
OHPAU
24
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$9.98M 1.03%
1,006,085
-93,915
-9% -$936K
STXS icon
25
Stereotaxis
STXS
$130M
$1.86M 0.19%
+192,928
New +$1.52M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Iron Triangle Partners held 36 positions worth $971M, up 23% from $786M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Iron Triangle Partners deployed $141M of net new capital in Q2 2021, opening 9 new positions and adding to 10 existing holdings. Its largest new stake was Humana: 181,512 shares worth $80.4M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

On the sell side, the largest reduction was Zimmer Biomet, an estimated $25.8M trimmed.

  • Iron Triangle Partners's largest Q2 2021 buy was Humana: 181,512 shares worth $80.4M.
  • Iron Triangle Partners added most to Guardant Health in Q2 2021, an estimated $33.6M increase.
  • Iron Triangle Partners's biggest Q2 2021 reduction was Zimmer Biomet, cutting an estimated $25.8M.
  • Iron Triangle Partners fully exited UnitedHealth in Q2 2021, selling an estimated $59.5M.
  • Iron Triangle Partners's ten largest holdings make up 60% of its $971M portfolio in Q2 2021.
  • Iron Triangle Partners opened 9 new positions and closed 10 in Q2 2021.
  • Iron Triangle Partners's portfolio value rose 23% quarter-over-quarter to $971M.

Based on Iron Triangle Partners's 13F filing for Q2 2021, filed 16 Aug 2021.